- Home
- ABEO vs DSM Comparison
ABEO vs DSM Comparison
Compare ABEO & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- DSM
- Stock Information
- Founded
- ABEO 1974
- DSM 1989
- Country
- ABEO United States
- DSM United States
- Employees
- ABEO N/A
- DSM N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- ABEO Health Care
- DSM Finance
- Exchange
- ABEO Nasdaq
- DSM Nasdaq
- Market Cap
- ABEO 256.9M
- DSM 275.8M
- IPO Year
- ABEO 1980
- DSM N/A
- Fundamental
- Price
- ABEO $5.57
- DSM $5.65
- Analyst Decision
- ABEO Strong Buy
- DSM
- Analyst Count
- ABEO 6
- DSM 0
- Target Price
- ABEO $18.00
- DSM N/A
- AVG Volume (30 Days)
- ABEO 1.1M
- DSM 161.7K
- Earning Date
- ABEO 08-11-2025
- DSM 01-01-0001
- Dividend Yield
- ABEO N/A
- DSM 3.97%
- EPS Growth
- ABEO N/A
- DSM N/A
- EPS
- ABEO N/A
- DSM N/A
- Revenue
- ABEO N/A
- DSM N/A
- Revenue This Year
- ABEO N/A
- DSM N/A
- Revenue Next Year
- ABEO $323.51
- DSM N/A
- P/E Ratio
- ABEO N/A
- DSM N/A
- Revenue Growth
- ABEO N/A
- DSM N/A
- 52 Week Low
- ABEO $3.93
- DSM $4.69
- 52 Week High
- ABEO $7.32
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- ABEO 37.51
- DSM 55.13
- Support Level
- ABEO $5.66
- DSM $5.55
- Resistance Level
- ABEO $6.24
- DSM $5.60
- Average True Range (ATR)
- ABEO 0.26
- DSM 0.04
- MACD
- ABEO -0.08
- DSM 0.01
- Stochastic Oscillator
- ABEO 8.08
- DSM 91.67
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.